Search

Author/Creator Langenickel, Thomas H.

1. C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function. Issue 3 (5th August 2016)

Authors:
Buttgereit, Jens; Shanks, Julia; Li, Dan; Hao, Guoliang; Athwal, Arvinder; Langenickel, Thomas H.; Wright, Hannah; da Costa Goncalves, Andrey C.; Monti, Jan; Plehm, Ralph; Popova, Elena; Qadri, Fatimunnisa; Lapidus, Irina; Ryan, Brent; Özcelik, Cemil; Paterson, David J.; Bader, Michael; Herring, ...
Journal:
Cardiovascular research
Issue:
Volume 112: Issue 3(2016)
Page Start:
637
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension. Issue 1 (January 2018)

Authors:
Engeli, Stefan; Stinkens, Rudi; Heise, Tim; May, Marcus; Goossens, Gijs H.; Blaak, Ellen E.; Havekes, Bas; Jax, Thomas; Albrecht, Diego; Pal, Parasar; Tegtbur, Uwe; Haufe, Sven; Langenickel, Thomas H.; Jordan, Jens
Journal:
Hypertension
Issue:
Volume 71:Issue 1(2018:Jan.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide. (20th February 2018)

Authors:
Ayalasomayajula, Surya; Schuehly, Uwe; Pal, Parasar; Chen, Fabian; Zhou, Wei; Sunkara, Gangadhar; Langenickel, Thomas H.
Journal:
British journal of clinical pharmacology
Issue:
Volume 84:Number 5(2018:Nov.)
Page Start:
926
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. Issue 4 (August 2016)

Authors:
Kobalava, Zhanna; Kotovskaya, Yulia; Averkov, Oleg; Pavlikova, Elena; Moiseev, Valentine; Albrecht, Diego; Chandra, Priya; Ayalasomayajula, Surya; Prescott, Margaret F.; Pal, Parasar; Langenickel, Thomas H.; Jordaan, Pierre; Rajman, Iris
Journal:
Cardiovascular therapeutics
Issue:
Volume 34:Issue 4(2016:Aug.)
Page Start:
191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial. Issue 2 (June 2015)

Authors:
Emami, Hamed; Vucic, Esad; Subramanian, Sharath; Abdelbaky, Amr; Fayad, Zahi A.; Du, Shuyan; Roth, Eli; Ballantyne, Christie M.; Mohler, Emile R.; Farkouh, Michael E.; Kim, Joonyoung; Farmer, Matthew; Li, Li; Ehlgen, Alexander; Langenickel, Thomas H.; Velasquez, Linda; Hayes, Wendy; Tawakol, Ahmed
Journal:
Atherosclerosis
Issue:
Volume 240:Issue 2(2015)
Page Start:
490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects. (8th March 2016)

Authors:
Langenickel, Thomas H.; Tsubouchi, Chiaki; Ayalasomayajula, Surya; Pal, Parasar; Valentin, Marie‐Anne; Hinder, Markus; Jhee, Stanford; Gevorkyan, Hakop; Rajman, Iris
Journal:
British journal of clinical pharmacology
Issue:
Volume 81:Number 5(2016:May)
Page Start:
878
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗